What ICD-10 (International Classification of Diseases, 10th Revision) code should be used for approval of vitamin D laboratory tests?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Codes for Vitamin D Laboratory Testing

For vitamin D testing to be approved by insurance, use ICD-10 code E55.9 (Vitamin D deficiency, unspecified) as the primary diagnosis code, or more specific codes based on clinical context such as M81.0 (osteoporosis), E83.31 (familial hypophosphatemia), or disease-specific codes when vitamin D testing is part of disease management rather than screening.

Understanding the Coding Context

The key issue is that routine screening for vitamin D deficiency in asymptomatic adults is not recommended by major guidelines, which affects insurance coverage 1, 2, 3. However, testing becomes appropriate—and therefore billable—when there are specific clinical indications 2.

Primary ICD-10 Codes for Vitamin D Testing

When Vitamin D Deficiency is Suspected or Documented

  • E55.9 - Vitamin D deficiency, unspecified (most commonly used for initial testing when deficiency is suspected) 1
  • E55.0 - Rickets, active (for children with suspected nutritional rickets)
  • M83.9 - Adult osteomalacia, unspecified (for adults with bone pain, muscle weakness, or suspected osteomalacia)

When Testing is Part of Disease Management

Testing should be coded as disease management rather than screening when patients have 2:

  • M81.0 - Age-related osteoporosis without current pathological fracture
  • M80.0 - Age-related osteoporosis with current pathological fracture
  • N18.3-N18.5 - Chronic kidney disease, stage 3-5 (CKD patients with GFR <45 mL/min per 1.73 m² should have vitamin D evaluated as part of metabolic bone disease assessment) 1
  • E83.31 - Familial hypophosphatemia
  • K90.0 - Celiac disease (malabsorption disorder)
  • K90.9 - Intestinal malabsorption, unspecified

Clinical Scenarios That Justify Testing

High-Risk Populations Where Testing May Be Appropriate

Document one or more of these conditions to support medical necessity 1, 2:

  • Z91.11 - Patient's noncompliance with dietary regimen (for low vitamin D intake)
  • E66.9 - Obesity, unspecified (obesity may be associated with low vitamin D levels)
  • Z77.123 - Contact with and (suspected) exposure to radon and other naturally occurring radiation (minimal sun exposure)
  • Z57.1 - Occupational exposure to radiation (for those with limited sun exposure due to work)

Disease States Where Testing is Disease Management

  • M35.9 - Systemic involvement of connective tissue, unspecified (autoimmune diseases) 2
  • O14.9 - Pre-eclampsia, unspecified (pregnancy-related, as vitamin D may lower preeclampsia risk) 3
  • R73.03 - Prediabetes (high-risk prediabetes patients may benefit from vitamin D) 3

Critical Coding Pitfalls to Avoid

Do Not Use Screening Codes

  • Avoid Z13.xx codes (encounter for screening) as routine screening is not supported by evidence and will likely be denied 1, 2, 3
  • The U.S. Preventive Services Task Force gives an "I" statement (insufficient evidence) for routine screening in asymptomatic adults 2

Document Medical Necessity

Insurance denial is common when 2:

  • Testing is performed without documented risk factors
  • Testing is coded as routine screening rather than disease management
  • There is no documented clinical indication in the medical record

Monitoring After Supplementation

When retesting vitamin D levels after supplementation 1, 4:

  • Use E55.9 (Vitamin D deficiency) if deficiency was previously documented
  • Wait at least 3 months before retesting to allow plateau levels 1, 4
  • Document that testing is for monitoring response to treatment

Special Population Considerations

Chronic Kidney Disease Patients

For CKD patients with GFR <45 mL/min per 1.73 m² 1:

  • Primary code: N18.3 (CKD stage 3), N18.4 (CKD stage 4), or N18.5 (CKD stage 5)
  • Secondary code: E55.9 (Vitamin D deficiency) if suspected
  • This population requires vitamin D evaluation as part of metabolic bone disease assessment

Pregnant Patients

For pregnancy-related testing 3:

  • O09.xx codes (supervision of high-risk pregnancy) combined with
  • E55.9 (Vitamin D deficiency) if deficiency is suspected
  • Document that testing is for disease management, not routine prenatal screening

Pediatric Patients

For children aged 1-18 years 3:

  • E55.0 (Rickets, active) if rickets is suspected
  • E55.9 (Vitamin D deficiency) for general deficiency concerns
  • Document risk factors such as limited sun exposure, dark skin pigmentation, or inadequate dietary intake

Documentation Requirements

To support medical necessity, document 1, 2:

  • Specific risk factors (limited sun exposure, malabsorption, obesity, dark skin pigmentation)
  • Clinical signs or symptoms (bone pain, muscle weakness, fractures)
  • Underlying conditions requiring vitamin D monitoring
  • Previous vitamin D deficiency requiring follow-up

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vitamin D Level Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism, 2024

Guideline

Vitamin D Testing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.